Cargando…
Accurate Prediction of Inhibitor Binding to HIV-1 Protease Using CANDOCK
The human immunodeficiency virus 1 (HIV-1) protease is an important target for treating HIV infection. Our goal was to benchmark a novel molecular docking protocol and determine its effectiveness as a therapeutic repurposing tool by predicting inhibitor potency to this target. To accomplish this, we...
Autores principales: | Falls, Zackary, Fine, Jonathan, Chopra, Gaurav, Samudrala, Ram |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801943/ https://www.ncbi.nlm.nih.gov/pubmed/35111726 http://dx.doi.org/10.3389/fchem.2021.775513 |
Ejemplares similares
-
Shotgun drug repurposing biotechnology to tackle epidemics and pandemics
por: Mangione, William, et al.
Publicado: (2020) -
Shotgun drug repurposing biotechnology to tackle epidemics and pandemics
por: Mangione, William, et al.
Publicado: (2020) -
Improved prediction of HIV-1 protease-inhibitor binding energies by molecular dynamics simulations
por: Jenwitheesuk, Ekachai, et al.
Publicado: (2003) -
Optimal COVID-19 therapeutic candidate discovery using the CANDO platform
por: Mangione, William, et al.
Publicado: (2022) -
Effective holistic characterization of small molecule effects using heterogeneous biological networks
por: Mangione, William, et al.
Publicado: (2023)